Back to results
CompletedPhase 2

Dose EScalation Induction of EvERolimus

NCT02387099

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sana Klinikum Offenbach / German Breast Group

Neu-Isenburg, Hesse, Germany

+13 additional locations

View on ClinicalTrials.gov
Dose EScalation Induction of EvERolimus — TrialFind